Pay in 4 interest-free payments of $6.46 Learn more
Ships within 48 hours · Estimated delivery Aug 30 - Sep 4
The phase 2b SYMMETRY trial, a multicenter, randomized, double-blind, placebo-controlled study, included 181 patients with compensated cirrhosis (Child-Pugh A) due to MASH (78% with histological diagnosis and 22% with cryptogenic cirrhosis attributed to MASH) assigned to receive efruxifermin at doses of 28 or 50 mg, or placebo (1:1:1), for 96 weeks
Start with the GLP-1 must-haves that match your actual medication routine and personal needs
Joseph M
What is Klow Blend
US$ 23.06
US$ 29.34
US$ 25.97
US$ 26.71
